Cargando…
Non-Vitamin K Oral Anticoagulant After Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis
Objective: We aimed to compare non-vitamin K oral anticoagulants (NOACs) with a traditional antithrombotic such as vitamin K antagonist (VKA) and antiplatelet agents in patients after transcatheter aortic valve replacement (TAVR). Methods: We conducted a search in PubMed, EMBASE, and the Cochrane Li...
Autores principales: | Li, Dongxu, Ma, Xiaofang, Zhou, Xu, Qian, Yongjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880334/ https://www.ncbi.nlm.nih.gov/pubmed/35222019 http://dx.doi.org/10.3389/fphar.2022.755009 |
Ejemplares similares
-
Non‐vitamin K oral anticoagulants versus vitamin K antagonists in post transcatheter aortic valve replacement patients with clinical indication for oral anticoagulation: A meta‐analysis
por: Chen, Yi‐feng, et al.
Publicado: (2022) -
Late Clinical Valve Thrombosis After Transcatheter Aortic Valve Replacement Despite Non-Vitamin K Anticoagulant
por: Carmeliet, Tom, et al.
Publicado: (2021) -
Comparing Vitamin K Antagonists and Direct Oral Anticoagulants in
Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve
Replacement: A Meta-Analysis
por: Lee, Wei-Chieh, et al.
Publicado: (2023) -
Efficacy and safety of antithrombotic therapy with non-vitamin K
antagonist oral anticoagulants after transcatheter aortic valve replacement: a
systematic review and meta-analysis
por: An, Qing, et al.
Publicado: (2021) -
Novel oral anticoagulants versus vitamin K antagonists in transcatheter aortic valve replacement treated patients—Patients' vulnerability still matters
por: Tarantini, Giuseppe, et al.
Publicado: (2022)